In the United States, about 30-40% of donor hearts aren't considered for transplant due to inadequate function in the donor. This leads to a drop in the number of donated hearts that are available to ...

Organ transplants are notoriously finicky procedures with narrow timespans of viability, but a new FDA approval for TransMedics’ portable transport system has opened the window for heart transplants a ...

LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the start of a limited commercial release for the Essenz™ Perfusion ...

LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance ...

Mayo Clinic doctors are using innovation to improve the lives of people who suffer from congestive heart failure and other chronic heart conditions. The Organ Care System, also known as "heart in a ...

Transmedics Group ((TMDX)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...

TransMedics Group, Inc. TMDX recently announced its receipt of the FDA’s premarket approval of its OCS Heart System for use with organs from donors after brain death (“DBD”). The system is indicated ...

The TransMedics Organ Care System (OCS) Heart System got closer to regulatory approval as it emerged victorious from a contentious FDA advisory committee meeting. Members of the agency's Circulatory ...

TransMedics Group Inc (NASDAQ:TMDX) stock jumped 6.7% after the company announced that the U.S. Food and Drug Administration (FDA) granted conditional approval for its Investigational Device Exemption ...

A heart perfusion imaging scan, or myocardial perfusion scan, is a test that tells doctors how well a person’s heart pumps blood. Doctors may use this test when diagnosing the cause of chest pain or ...